Cannabis Organigram takes top Canadian market share position with Motif Labs acquisition The C$90-million-dollar deal makes Organigram the nation's top vape company too Rowan DunneDecember 6, 2024
Cannabis Organigram Holdings faces challenges after Health Canada’s edibles ruling Company forced to reevaluate as government entity reclassifies cannabis products Zartasha MushtaqMarch 27, 2024
Cannabis Organigram invests $8M in Phylos Bioscience to commercialize THCV products The THCV vape and gummies will be launched by Organigram this summer or fall Rowan DunneMay 30, 2023
Cannabis Organigram enters Germany’s medical cannabis market The company will be supplying Germany's Sanity Group with high-grade medical cannabis flower Rowan DunneMay 23, 2023
COVID-19 Organigram blames weak sales on delayed value product launch Moncton-based producer says Health Canada axing its Trailer Park Buds bulk product also contributed to a Q3 revenue drop Jared GnamJuly 21, 2020
COVID-19 Organigram lays off 220 workers, warns of declining weed sales Moncton-based company will also cut production and expects writedowns due to Covid-19 Jared GnamJuly 3, 2020
COVID-19 Shopify moves offices online to keep employees safe from COVID-19 'Office centricity' might be over for some, but majority of cannabis industry can't work remotely Michelle GamageMay 21, 2020
Canada Lack of clarity on promotional rules perpetuates haze of regulatory guesswork Without clear guidance from regulators, brands like the Trailer Park Buds coming to market leads to open speculation and little else Nick LabaMay 1, 2020
Alternative Energy Organigram’s tainted weed not linked to illness: NS court Class action lawsuit unable to prove trace amounts of pesticides made users sick Michelle GamageMay 1, 2020
COVID-19 Organigram lays off 400 workers due to COVID-19 The producer will keep a skeleton crew employed at its New Brunswick facility to keep up with Canadian market demand Jared GnamApril 7, 2020